Biktarvy, formally known as bictegravir sulfate, is a powerful single-tablet treatment for controlling HIV infection. This formula combines three essential antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the HIV's ability to copy within the body, remarkably decreasing the viral quantity. For many i